WGRX Stock - Wellgistics Health, Inc.
Unlock GoAI Insights for WGRX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $18.13M | N/A | $32.78M |
| Gross Profit | $1.77M | N/A | $5.75M |
| Gross Margin | 9.7% | N/A | 17.5% |
| Operating Income | $-6,145,132 | $-2,880,603 | $-3,422,729 |
| Net Income | $-6,856,226 | $-2,895,684 | $-2,743,800 |
| Net Margin | -37.8% | N/A | -8.4% |
| EPS | $-0.13 | $-0.06 | $-0.06 |
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Visit WebsiteEarnings History & Surprises
WGRXEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 9, 2026 | — | — | — | — |
Q4 2025 | Nov 19, 2025 | — | $-0.44 | — | — |
Q3 2025 | Aug 19, 2025 | — | $-0.11 | — | — |
Q2 2025 | May 12, 2025 | — | $-0.62 | — | — |
Latest News
Wellgistics Health Begins Commercial Launch Of Diabetes Prescription Drug Brenzavvy To Wellgistics Pharmacy Network
📈 PositiveWellgistics Health Announces Dream Bowl 2026 Meme Coin Distribution To Stockholders, One Coin For Every One Share Owned On Record Date
➖ NeutralDatavault AI Grants Wellgistics Health An Exclusive License To Its Proprietary Smart-Contract Intellectual Property For Use In Wellgistics' Pharmacychain And Einsteinrx Platforms
📈 PositiveWellgistics Health Expands Agreement With Tollo Health To Provide GLP-1 Companion Muscle Loss Medical Food To Its Over 6.5K Independent Pharmacy Network, Physicians
📈 PositiveWellgistics Health Launches EinsteinRx AI Prescription Management Hub, Integrating 6,500+ Pharmacies, Physicians And Manufacturers; Payer Onboarding Begins Q4 2025
📈 PositiveWellgistics Health Signs Letter Of Intent To Acquire Kare Rx Hub; Financial Terms Not Disclosed
📈 PositiveWellgistics Health shares are trading lower, pulling back after surging on Friday.
📉 NegativeDatavault AI shares are trading higher after Wellgistics Health recently signed a non-binding letter of intent to integrate Datavault's blockchain-enabled PharmacyChain smart contract technology into its infrastructure.
📈 PositiveWellgistics Health shares are trading higher after the company signed a non-binding letter of intent with Datavault AI to integrate its blockchain-enabled PharmacyChain smart contract technology into Wellgistics' infrastructure.
📈 PositiveWellgistics Health Reappoints Prashant Patel As President And Interim-CEO; Appoints Eric Sherb As Interim-CFO
➖ NeutralOn October 6, 2025 Wellgistics Health CEO, COO, And CFO Announced Resignation From Company; Eric Sherb Appointed Interim CFO
📉 NegativeWellgistics Health And TheracosBio Partner To Expand Brenzavvy Access Through 6,500+ Pharmacies
📈 PositiveWellgistics Health shares are trading lower after the company announced it priced its $5 million public offering with Warrants to purchase 7,142,862 shares at $0.70 per share.
📉 NegativeReported Earlier, Wellgistics Health Prices $5M Public Offering With Warrants To Purchase 7,142,862 Shares At $0.70 Per Share
📈 PositiveWellgistics Health Rolls Out New Capital Access Program In Collaboration With RxERP Financial To Provide $350K Financing Per Pharmacy, $1M Per Wholesaler Or Manufacturer In US
📈 PositiveWellgistics Health Announces Public Offering Of Common Stock, Warrants, And Pre-Funded Warrants; Size Or Amount Not Disclosed
➖ NeutralWellgistics Health H1 2025 Revenue On Pro Forma Basis $18.65M Up From $18.25M YoY
📈 PositiveFrequently Asked Questions about WGRX
What is WGRX's current stock price?
What is the analyst price target for WGRX?
What sector is Wellgistics Health, Inc. in?
What is WGRX's market cap?
Does WGRX pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to WGRX for comparison